Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

49results about How to "Minimizes delivery" patented technology

Methods and apparatus to achieve a closure of a layered tissue defect

Methods for treating anatomic tissue defects such as a patent foramen ovate generally involve positioning a distal end of a catheter device at the site of the defect, exposing a housing and energy transmission member from the distal end of the catheter, engaging the housing with tissues at the site of the defect, applying suction or other approximating tool to the tissue via the housing to bring the tissue together, and applying energy to the tissue with the energy transmission member or to deliver a clip or fixation device to substantially close the defect. Apparatus generally include a catheter body, a housing extending from a distal end of the catheter body for engaging tissue at the site of the defect, and further adapted to house a fusing or fixation device such as an energy transmission member adjacent a distal end of the housing, or a clip or fixation delivery element.
Owner:TERUMO KK

Intravascular Tissue Disruption

Disrupting tissue and devices and systems for disrupting tissue. The disclosure describes ways to deliver moieties to a target tissue, where the target tissue in general is not at the point of introduction, in such a way that minimal damage is produced in the tissue at the point of introduction. In some embodiments this is accomplished by jetting fluid at high velocity into the target tissue. The disclosure further describes novel agents deliverable in such systems for use in remodeling tissues. Some of these agents comprise a liquid while others do not. Additionally, although not specifically described in detail much of the disclosure may additionally be used in the delivery of therapeutic drugs.
Owner:SHIFAMED HLDG

System and method for controlling delivery of ablation energy to tissue

A system for controlling delivery of ablation energy by an ablation catheter to tissue in a body is provided. The system includes an electronic control unit configured to determine, responsive to a measurement signal from the ablation catheter, a value for a characteristic associated with the delivery of ablation energy to the tissue. In one embodiment, the characteristic is the degree of contact between the ablation catheter and the tissue. The unit is further configured to generate a control signal, responsive to the determined value of the characteristic, to control an amount of energy delivered from an ablation delivery element on the ablation catheter to the tissue. The amount of energy varies in response to the determined value of the characteristic when the determined value of the characteristic meets a predetermined condition relative to a threshold value for the characteristic.
Owner:ST JUDE MEDICAL ATRIAL FIBRILLATION DIV

Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract

Controlled release oral dosage forms are provided for the continuous, sustained administration of a pharmacologically active agent to the upper gastrointestinal tract of a patient in whom the fed mode as been induced. The majority of the agent is delivered, on an extended release basis, to the stomach, duodenum and upper regions of the small intestine, with drug delivery in the lower gastrointestinal tract and colon substantially restricted. The dosage form comprises a matrix of a biocompatible, hydrophilic, erodible polymer with an active agent incorporated therein, wherein the polymer is one that both swells in the presence of water and gradually erodes over a time period of hours, with swelling and erosion commencing upon contact with gastric fluid, and drug release rate primarily controlled by erosion rate.
Owner:DEPOMED SYST INC

System and method for controlling delivery of ablation energy to tissue

A system for controlling delivery of ablation energy by an ablation catheter to tissue in a body is provided. The system includes an electronic control unit configured to determine, responsive to a measurement signal from the ablation catheter, a value for a characteristic associated with the delivery of ablation energy to the tissue. In one embodiment, the characteristic is the degree of contact between the ablation catheter and the tissue. The unit is further configured to generate a control signal, responsive to the determined value of the characteristic, to control an amount of energy delivered from an ablation delivery element on the ablation catheter to the tissue. The amount of energy varies in response to the determined value of the characteristic when the determined value of the characteristic meets a predetermined condition relative to a threshold value for the characteristic.
Owner:ST JUDE MEDICAL ATRIAL FIBRILLATION DIV

Oxygen conservation system for commercial aircraft

An emergency oxygen supply system for use on aircraft in the event of a loss in cabin pressure is configured for delivering allotments of oxygen and timing the delivery such allotments to each passenger so as maximize the efficiency of the transfer of such oxygen into the passenger's bloodstream. The delivery of each allotment is selected so that the entire allotment is available for inhalation into the region of the lung most efficient at oxygen transfer while the volume of the allotment is selected to substantially coincide with the volume of such region of the lung.
Owner:BE INTPROP

Treatment plan optimization method for radiotherapy

Systems and methods for providing radiosurgery treatment to a patient by combining methods from both traditional radiosurgery and radiotherapy are disclosed. A dose sufficient to kill tissue is applied to a target area while a steep drop off, or gradient, is provided at the border between the target area and adjacent areas so that other portions of the brain or nearby structures or organs are not damaged. The treatment plan is optimized by using both measures known in the art along with a new gradient index or curve that indicates the amount of the drop off at the border between the target area and the surrounding tissues.
Owner:SIEMENS HEALTHINEERS INT AG

Intranasal administration

Intranasal administration of proteins, such as insulin and insulin analogues, in particular immunogenic proteins to the upper posterior region of a nasal cavity of a subject, and in particular the olfactory bulb region.
Owner:OPTINOSE INC

Method and apparatus for self-powered vehicular sensor node using magnetic sensor and radio transceiver

The invention includes a vehicular sensor node, circuit apparatus and their operations. Power from power source is controlled for delivery to radio transceiver and magnetic sensor, based upon a task trigger and task identifier. The radio transceiver and the magnetic sensor are operated based upon the task identifier, when the task trigger is active. The power source, radio transceiver, magnetic sensor, and circuit apparatus are enclosed in vehicular sensor node, placed upon pavement and operating for at least five years without replacing the power source components. Magnetic sensor preferably uses the magnetic resistive effect to create magnetic sensor state. Radio transceiver preferably implements version of a wireless communications protocol. The circuit apparatus may further include light emitting structure to visibly communicate during installation and / or testing, and second light emitting structure used to visibly communicate with vehicle operators. Making filled shell and vehicular sensor node from circuit apparatus.
Owner:SENSYS NETWORKS

Electrodes coated with treating agent and uses thereof

An object of the invention is to provide a method for delivery of macromolecules into biological cells in the tissues of a patient and includes the steps of: (a) providing electrodes (16) in an electrode assembly (12), wherein the electrodes have fixed electrode surfaces (42) which are coated with at least one static layer of electrode releasable molecules (44) to be delivered; (b) providing a waveform generator (15) for generating electric fields; (c) establishing electrically conductive pathways between the electrodes (16) and the waveform generator (15); (d) locating the electrodes (16) such that the biological cells are situated therebetween, and (g) providing electric fields in the form of pulse waveforms from the waveform generator (15) to the electrodes (16), such that molecules in the at least one static layer of the electrode releasable molecules (44) on the electrodes (16) are delivered into the biological cells. The electrode releasable molecules (44) can be either electric field separable molecules and / or solvent separable material. Another object of the invention is to provide an apparatus for carrying out the method of the invention. The static-coated electrode assembly (12) can be provided in a sterile package (24), from which the electrode assembly (12) is removed prior to use. The statically-coated electrode assembly (12) can be in a form of a disposable assembly (12) which is removable and replaceable from an electrode assembly holder (13).
Owner:CELLECTIS SA

Method of treating a patient having pulmonary hypertension by long term no therapy

ActiveUS20150000659A1Efficiently administeredMinimizes deliveryRespiratory masksMedical devicesBreathingBiology
The invention concerns a nasal cannula assembly (10) adapted to deliver gases to a patient comprising a first compartment (1) and a second compartment (2) separated by a separation wall (6); a pair of nasal prongs (5) in fluid communication with the first compartment (1); the first compartment (1) comprising a first inlet (11) for introducing a first gas into said first compartment (1); the second compartment (2) comprising a second inlet (2) for introducing a second gas into said second compartment (2); and the separation wall (6) comprising at least one valve element (3) for controlling the passage of gas from the second compartment (2) to the first compartment (1). The invention concerns also a breathing assistance apparatus comprising a source of NO gas, and said nasal cannula assembly (10) in fluid communication with said source of NO gas.
Owner:LAIR LIQUIDE SA POUR LETUDE & LEXPLOITATION DES PROCEDES GEORGES CLAUDE

Nasal cannula assembly with flow control passage communicating with a deformable reservoir

The invention concerns a nasal cannula assembly (10) adapted to deliver gases to a patient comprising a first compartment (1) and a second compartment (2) separated by a separation wall (6); a pair of nasal prongs (5) in fluid communication with the first compartment (1); the first compartment (1) comprising a first inlet (11) for introducing a first gas into said first compartment (1); the second compartment (2) comprising a second inlet (2) for introducing a second gas into said second compartment (2); and the separation wall (6) comprising at least one flow restriction element (35) for controlling the passage of gas from the second compartment (2) to the first compartment (1).
Owner:LAIR LIQUIDE SA POUR LETUDE & LEXPLOITATION DES PROCEDES GEORGES CLAUDE

Treatment Plan Optimization Method For Radiosurgery

Systems and methods for providing radiosurgery treatment to a patient by combining methods from both traditional radiosurgery and radiotherapy are disclosed. A dose sufficient to kill tissue is applied to a target area while a steep drop off, or gradient, is provided at the border between the target area and adjacent areas so that other portions of the brain or nearby structures or organs are not damaged. The treatment plan is optimized by using both measures known in the art along with a new gradient index or curve that indicates the amount of the drop off at the border between the target area and the surrounding tissues.
Owner:SIEMENS HEALTHINEERS INT AG

Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same

ActiveUS20180141953A1Avoid destabilizationPreventing stabilizing breathing rhythmOrganic active ingredientsPowder deliveryDiseaseMedicine
The present invention includes compounds that are useful in the prevention and / or treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of preventing and / or treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound and / or composition of the invention. The present invention further includes a method of preventing destabilization or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound and / or composition of the invention.
Owner:NEURAD LTD

Breathing assistance apparatus for delivery of nitric oxide to a patient by means of a nasal cannula assembly with flow control passage

The invention concerns a breathing assistance apparatus having a source of Nitric Oxide in fluid communication with a nasal cannula assembly (10) adapted to deliver gases to a patient comprising a first compartment (1) and a second compartment (2) separated by a separation wall (6); a pair of nasal prongs (5) in fluid communication with the first compartment (1); the first compartment (1) comprising a first inlet (11) for introducing a first gas into said first compartment (1); the second compartment (2) comprising a second inlet (2) for introducing a second gas into said second compartment (2); and the separation wall (6) comprising at least one flow restriction element (35) for controlling the passage of gas from the second compartment (2) to the first compartment (1).
Owner:LAIR LIQUIDE SA POUR LETUDE & LEXPLOITATION DES PROCEDES GEORGES CLAUDE

System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation

Embodiments of the invention provide methods for the transdermal delivery of therapeutic agents for the treatment of addictive cravings e.g., from nicotine. An embodiment of a method for such delivery comprises positioning at least one electrode assembly in electrical communication with a patient's skin. The assembly includes a solution comprising a therapeutic agent which passively diffuses into skin. A dose of agent is delivered from the assembly into skin during a first period using a first current having a characteristic e.g., polarity and magnitude, to repel agent out of the assembly. During a second period, a second current having a characteristic to attract agent is used to retain agent in the assembly such that delivery of agent into skin is minimized. In particular embodiments, a dose of agent may be delivered on-demand using an input from the patient using an inhalation sensing device which mimics an inhaled form of tobacco.
Owner:INCUBE LABS

Femtosecond laser apparatus using laser diode optical pumping module

The present invention provides a femtosecond laser apparatus using laser diode optical pumping. To provide a stable mode locking and improve power stability and beam stability in an ultrafast laser such as a femtosecond laser, optical mounts which have mounted thereon optical parts of a diode pumping unit are mechanically engaged using bars of low thermal expansion coefficients and form a pumping module, and the pumping module is maximally separated from a laser platform or case.
Owner:KOREA ELECTROTECH RES INST

Breathing assistance apparatus for delivery of nitric oxide to a patient by means of a nasal cannula assembly with flow control passage

The invention concerns a breathing assistance apparatus having a source of Nitric Oxide in fluid communication with a nasal cannula assembly (10) adapted to deliver gases to a patient comprising a first compartment (1) and a second compartment (2) separated by a separation wall (6); a pair of nasal prongs (5) in fluid communication with the first compartment (1); the first compartment (1) comprising a first inlet (11) for introducing a first gas into said first compartment (1); the second compartment (2) comprising a second inlet (2) for introducing a second gas into said second compartment (2); and the separation wall (6) comprising at least one flow restriction element (35) for controlling the passage of gas from the second compartment (2) to the first compartment (1).
Owner:LAIR LIQUIDE SA POUR LETUDE & LEXPLOITATION DES PROCEDES GEORGES CLAUDE

Continuous Web Sheet Defect Analytics, Classification and Remediation for Enhancing Equipment Efficiency and Throughput

ActiveUS20190010005A1Enhances machine run-timeMinimizing late deliveryPaper-making machinesMaterial analysisDiagnostic modalitiesMetal foil
Monitoring continuous repetitive web sheet defects to determine the causes of such defects by creating unique diagnostic patterns associated with selected components of a web-making machine and employing pattern recognition techniques to analyze and classify web-sheet dynamic and deterministic defect patterns, and identify their root causes. Corrective actions can be effected thereby enhancing machine run-time to minimize late deliveries and improves overall product quality. The technique which is integrated with quality control system can be applied to the manufacturer of paper, packaging, rubber sheets, plastic film, metal foil, and the like.
Owner:HONEYWELL INC

Method for transmission and storage of wind energy

A method of transportation and storage of wind energy, comprising receiving wind energy from a wind turbine in the form of compressed gas, storing of at least a portion of the compressed gas in a pipe, venting a portion of the compressed gas to drive a motor to drive a generator to generate electrical power, and distributing the electrical power to one or more users.
Owner:BAUGH BENTON FREDERICK

Intranasal delivery of modafinil

Modafinil is selectively delivered to the brain, minimizing delivery to the blood, of a person in need thereof by administering to the person a therapeutically-effective dosage of modafinil, wherein the dosage is less than 1 mg, formulated in a lipid microemulsion (LME) and selectively delivered to the upper third of the nasal cavity. The method may be implemented with an intranasal pharmaceutical delivery device loaded with a modafinil composition and adapted to deliver the dosage to the upper third of the nasal cavity.
Owner:SRI INTERNATIONAL +1

Breathing control modulating compounds, and methods of making and using same

The present invention includes compounds that are useful in the prevention and / or treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of preventing and / or treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound and / or composition of the invention. The present invention further includes a method of preventing destabilization or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound and / or composition of the invention.
Owner:NEURAD LTD

Novel breathing control modulating compounds, and methods of using same

The present invention includes pyrimido[5,4-d]pyrimidines that are useful in the prevention and / or treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of preventing and / or treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of at least one compound of the invention. The present invention further includes a method of preventing destabilization or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of at least one compound of the invention.
Owner:NEURAD LTD

Method of delivering medical gases via a nasal cannula assembly with flow control passage communicating with a deformable reservoir

The invention concerns a nasal cannula assembly (10) adapted to deliver gases to a patient comprising a first compartment (1) and a second compartment (2) separated by a separation wall (6); a pair of nasal prongs (5) in fluid communication with the first compartment (1); the first compartment (1) comprising a first inlet (11) for introducing a first gas into said first compartment (1); the second compartment (2) comprising a second inlet (2) for introducing a second gas into said second compartment (2); and the separation wall (6) comprising at least one flow restriction element (35) for controlling the passage of gas from the second compartment (2) to the first compartment (1).
Owner:LAIR LIQUIDE SA POUR LETUDE & LEXPLOITATION DES PROCEDES GEORGES CLAUDE

Strip-Till Knife With Wings

ActiveUS20200137940A1Loosening compacted soilMinimize damagePlantingPloughsTree rootAgricultural science
A knife for creating berms in agricultural fields for strip-till farming is improved by adding wings on opposing sides of the knife edge that are configured to fracture and raise soil in a wider path for building a berm behind the knife. The wings can be swept back, angled downward from front to back, and angled downward from inside to outside, for better loosening compacted soil below the surface and creating improved berms rearward of the knife. The knife edge can be replaceable by removal of a single pin. If a difficult object is encountered, such as large rocks or tree roots, the knife can swing reward with respect to a supporting shank to minimize damage to the knife. Upon swinging reward, an agricultural product delivery tube rearward of the knife for depositing agricultural product into the berm can swing forward to minimize crimping of the delivery tube.
Owner:BLUE LEAF I P INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products